Table 1.
Characteristics of the study group.
| n = 116 | |
|---|---|
| Men, n | 87 (75%) |
| Age, years | 62 ± 5 |
| Hypertension, n | 81 (70%) |
| Current smokers, n | 9 (8%) |
| CCS class ≥ 2, n | 18 (16%) |
| T2D, n | 53 (46%) |
| T2D duration, months | 70 ± 84 |
| HISTORY OF AMI | |
| NSTEMI, n | 31 (27%) |
| STEMI n | 22 (19%) |
| REVASCULARIZATION | |
| PCI, n | 74 (64%) |
| CABG, n | 26 (22%) |
| ECHOCARDIOGRAPHY | |
| LVEF, % | 66 ± 8 |
| LVMI | 98 ± 22 |
| E/E′ | 9.5 ± 3.0 |
| CORONARY ANGIOGRAPHY | |
| Syntax score | 3.6 ± 5.0 |
| MEDICATION | |
| Oral antidiabetics, n | 41 (35%) |
| Insulin, n | 5 (4%) |
| Beta blockers, n | 103 (89%) |
| ACEI or ARB, n | 67 (58%) |
| Anticholesterol agents, n | 107 (92%) |
| Anticoagulants, n | 113 (97%) |
| Calcium antagonists, n | 19 (16%) |
| Nitrates, n | 27 (23%) |
| Diuretics, n | 37 (32%) |
| LABORATORY ANALYSES | |
| Fasting glucose, mmol·L−1 | 6.0 ± 1.1 |
| HbA1c, % | 6.2 ± 0.7 |
| Insulin, mU·L−1 | 14.0 ± 10.2 |
| Total cholesterol, mmol·L−1 | 4.0 ± 0.8 |
| LDL cholesterol, mmol·L−1 | 2.4 ± 0.7 |
| HDL cholesterol, mmol·L−1 | 1.2 ± 0.3 |
| Triglycerides, mmol·L−1 | 1.5 ± 0.8 |
| hs-CRP, mg·L−1 | 1.9 ± 3.0 |
| Creatinine, μmol·L−1 | 74 ± 14 |
| Albumin, mg·L−1 | 10.4 ± 20.7 |
| ACR, mg·mmol−1 | 1.2 ± 2.3 |
Values are the number of subjects (proportion) or means ± SD. CCS, Canadian Cardiovascular Society angina classification; T2D, type 2 diabetes; AMI, acute myocardial infarction; NSTEMI, non-ST segment elevation myocardial infarction; STEMI, ST segment elevation myocardial infarction; PCI, percutaneus coronary intervention; CABG, coronary artery by-pass grafting; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index; E/E′, ratio of early transmitral flow velocity to early diastolic mitral annulus velocity, ACEI, angiotensin conversion enzymes inhibitor; ARB, angiotensin receptor blocker; HbA1c, glycated hemoglobin; LDL, low-density lipoprotein; HDL, high-density lipoprotein; hs-CRP, high-sensitivity C-reactive protein; ACR, albumin-creatinine ratio.